Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences

SafetyAlerts
May 31, 2000

G.C. Hanford Mfg. Recalls Certain Lots of Cefuroxime for Injection

Princeton, NJ (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that G.C. Hanford Mfg. is recalling Cefuroxime for Injection USP, 7.5 mg, IM/IV use, pharmacy bulk package for preparing IV admixtures, Rx. because of Mislabeling - back panel of carton incorrectly declares 750 mg of Cefuroxime activity per mL instead of the correct per 8mL.

The product can be identified by codes: C2424 EXP 6/01, C2522 EXP 11/01, C2562 EXP 3/02.

FDA stated in its report that 9,150 vials of lot C2424 and 8,870 vials of lot C2522 were distributed to California, Florida, Illinois, Louisiana, Massachusetts, Missouri, Minnesota, Mississippi, North Carolina, New Jersey, New York, Pennsylvania, Tennessee, Texas, Utah, Washington state, Wisconsin, West Virginia, international. None of lot C8760 left the control of Bristol-Myers Squibb.

This ongoing Class III recall was initiated by the company, by letter dated May 9, 2000.  This is the first public notice issued by the FDA.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-392-0
NDC #59772-6569-1

Notice of this product warning was sent via email to SafeMail subscribers May 31, 2000.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

###

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.